Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update
2018-01-01 Cuccurullo, V.; di Stasio, G. D.; Evangelista, L.; Ciarmiello, A.; Mansi, L.
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine
2019-01-01 Carpanese, D.; Zorz, A.; Evangelista, L.; Salvarese, N.
Molecular imaging and immunotherapy
2019-01-01 Evangelista, L.
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer?
2018-01-01 Evangelista, L.; Cuppari, L.
The new era of cancer immunotherapy: what can molecular imaging do to help?
2017-01-01 Evangelista, L.; de Jong, M.; del Vecchio, S.; Cai, W.
Immunotherapy and 18F-FDG PET/CT: standardised procedures are needed
2019-01-01 Evangelista, L.; De Rimini, M. L.; Bianchi, A.; Schillaci, O.
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1
2019-01-01 Alongi, P.; Laudicella, R.; Desideri, I.; Chiaravalloti, A.; Borghetti, P.; Quartuccio, N.; Fiore, M.; Evangelista, L.; Marino, L.; Caobelli, F.; Tuscano, C.; Mapelli, P.; Lancellotta, V.; Annunziata, S.; Ricci, M.; Ciurlia, E.; Fiorentino, A.
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2
2019-01-01 Fiorentino, A.; Laudicella, R.; Ciurlia, E.; Annunziata, S.; Lancellotta, V.; Mapelli, P.; Tuscano, C.; Caobelli, F.; Evangelista, L.; Marino, L.; Quartuccio, N.; Fiore, M.; Borghetti, P.; Chiaravalloti, A.; Ricci, M.; Desideri, I.; Alongi, P.
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16
2020-01-01 Evangelista, Laura; Luca De Salvo, Gian; Zattoni, Fabio; Novara, Giacomo
Editorial comment
2016-01-01 Evangelista, L.
Prostate cancer imaging: when the game gets tough, the hard one gets done!
2018-01-01 Evangelista, L.; Sepulcri, M.; Maruzzo, M.
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer
2019-01-01 Evangelista, L.; Cuppari, L.; Burei, M.; Zorz, A.; Caumo, F.
New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature [Figure presented]
2016-01-01 Evangelista, L.; Briganti, A.; Fanti, S.; Joniau, S.; Reske, S.; Schiavina, R.; Stief, C.; Thalmann, G. N.; Picchio, M.
How can we optimize modem imaging techniques for breast cancer, with main reference to breast recurrence?
2013-01-01 Evangelista, L.; Morris, P. G.; Mansi, L.
Re: Response Assessment of 223Ra Treatment: Should a Fluorocholine PET/CT Be Performed?
2018-01-01 Evangelista, L.; Zorz, A.
The role of PET/CT in the evaluation of patients with urothelial cancer: a systematic review and meta-analysis
2018-01-01 Cervino, A. R.; Cuppari, L.; Reccia, P.; Burei, M.; Saladini, G.; Evangelista, L.
Translational molecular imaging in exocrine pancreatic cancer
2018-01-01 Cornelissen, B.; Knight, J. C.; Mukherjee, S.; Evangelista, L.; Xavier, C.; Caobelli, F.; Del Vecchio, S.; Rbah-Vidal, L.; Barbet, J.; de Jong, M.; van Leeuwen, F. W. B.
A competitive model for striatal action selection
2019-01-01 Bariselli, S; Fobbs, W C; Creed, M C; Kravitz, A V
The Role of Epigenetics in Primary Biliary Cholangitis
2022-01-01 Gerussi, Alessio; Paraboschi, Elvezia Maria; Cappadona, Claudio; Caime, Chiara; Binatti, Eleonora; Cristoferi, Laura; Asselta, Rosanna; Invernizzi, Pietro
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis
2022-01-01 Mulinacci, Giacomo; Palermo, Andrea; Gerussi, Alessio; Asselta, Rosanna; Gershwin, Merrill Eric; Invernizzi, Pietro
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update | 1-gen-2018 | Cuccurullo, V.; di Stasio, G. D.; Evangelista, L.; Ciarmiello, A.; Mansi, L. | |
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine | 1-gen-2019 | Carpanese, D.; Zorz, A.; Evangelista, L.; Salvarese, N. | |
Molecular imaging and immunotherapy | 1-gen-2019 | Evangelista, L. | |
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? | 1-gen-2018 | Evangelista, L.; Cuppari, L. | |
The new era of cancer immunotherapy: what can molecular imaging do to help? | 1-gen-2017 | Evangelista, L.; de Jong, M.; del Vecchio, S.; Cai, W. | |
Immunotherapy and 18F-FDG PET/CT: standardised procedures are needed | 1-gen-2019 | Evangelista, L.; De Rimini, M. L.; Bianchi, A.; Schillaci, O. | |
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 | 1-gen-2019 | Alongi, P.; Laudicella, R.; Desideri, I.; Chiaravalloti, A.; Borghetti, P.; Quartuccio, N.; Fiore, M.; Evangelista, L.; Marino, L.; Caobelli, F.; Tuscano, C.; Mapelli, P.; Lancellotta, V.; Annunziata, S.; Ricci, M.; Ciurlia, E.; Fiorentino, A. | |
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 | 1-gen-2019 | Fiorentino, A.; Laudicella, R.; Ciurlia, E.; Annunziata, S.; Lancellotta, V.; Mapelli, P.; Tuscano, C.; Caobelli, F.; Evangelista, L.; Marino, L.; Quartuccio, N.; Fiore, M.; Borghetti, P.; Chiaravalloti, A.; Ricci, M.; Desideri, I.; Alongi, P. | |
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 | 1-gen-2020 | Evangelista, Laura; Luca De Salvo, Gian; Zattoni, Fabio; Novara, Giacomo | |
Editorial comment | 1-gen-2016 | Evangelista, L. | |
Prostate cancer imaging: when the game gets tough, the hard one gets done! | 1-gen-2018 | Evangelista, L.; Sepulcri, M.; Maruzzo, M. | |
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer | 1-gen-2019 | Evangelista, L.; Cuppari, L.; Burei, M.; Zorz, A.; Caumo, F. | |
New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature [Figure presented] | 1-gen-2016 | Evangelista, L.; Briganti, A.; Fanti, S.; Joniau, S.; Reske, S.; Schiavina, R.; Stief, C.; Thalmann, G. N.; Picchio, M. | |
How can we optimize modem imaging techniques for breast cancer, with main reference to breast recurrence? | 1-gen-2013 | Evangelista, L.; Morris, P. G.; Mansi, L. | |
Re: Response Assessment of 223Ra Treatment: Should a Fluorocholine PET/CT Be Performed? | 1-gen-2018 | Evangelista, L.; Zorz, A. | |
The role of PET/CT in the evaluation of patients with urothelial cancer: a systematic review and meta-analysis | 1-gen-2018 | Cervino, A. R.; Cuppari, L.; Reccia, P.; Burei, M.; Saladini, G.; Evangelista, L. | |
Translational molecular imaging in exocrine pancreatic cancer | 1-gen-2018 | Cornelissen, B.; Knight, J. C.; Mukherjee, S.; Evangelista, L.; Xavier, C.; Caobelli, F.; Del Vecchio, S.; Rbah-Vidal, L.; Barbet, J.; de Jong, M.; van Leeuwen, F. W. B. | |
A competitive model for striatal action selection | 1-gen-2019 | Bariselli, S; Fobbs, W C; Creed, M C; Kravitz, A V | |
The Role of Epigenetics in Primary Biliary Cholangitis | 1-gen-2022 | Gerussi, Alessio; Paraboschi, Elvezia Maria; Cappadona, Claudio; Caime, Chiara; Binatti, Eleonora; Cristoferi, Laura; Asselta, Rosanna; Invernizzi, Pietro | |
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis | 1-gen-2022 | Mulinacci, Giacomo; Palermo, Andrea; Gerussi, Alessio; Asselta, Rosanna; Gershwin, Merrill Eric; Invernizzi, Pietro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista206
Data di pubblicazione
- 2020 - 202354
- 2010 - 2019134
- 2000 - 200917
- 1985 - 19891
Rivista
- CLINICAL AND TRANSLATIONAL IMAGING8
- FRONTIERS IN IMMUNOLOGY7
- CRITICAL REVIEWS IN ONCOLOGY HEMA...6
- CANCERS5
- EUROPEAN UROLOGY4
- INTERNATIONAL JOURNAL OF MOLECULA...4
- SEMINARS IN NUCLEAR MEDICINE4
- AUTOIMMUNITY REVIEWS3
- DIAGNOSTICS3
- FRONTIERS IN ONCOLOGY3
Keyword
- Humans45
- Animals16
- Neoplasms7
- Cardiovascular Diseases6
- Male6
- PET/CT6
- Autoimmunity5
- Biomarkers5
- Inflammation5
- Antineoplastic Agents4
Lingua
- eng150
- ita1
- spa1
Accesso al fulltext
- no fulltext194
- reserved11
- open1